Vimarsana.com

Latest Breaking News On - Zentalis pharmaceuticals inc - Page 1 : vimarsana.com

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Diana-hausman
Stifel-nicolaus
Zentalis-pharmaceuticals-inc
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-company-profile
Nasdaq
Decheng-capital
Vanguard-group-inc
Pricet-rowe-associates-inc
Zentalis-pharmaceuticals-stock-down
Institutional-trading-of-zentalis-pharmaceuticals
Hermes-inc

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Diana-hausman
Stifel-nicolaus
Zentalis-pharmaceuticals-stock-down
Zentalis-pharmaceuticals-inc
Vanguard-group-inc
Pricet-rowe-associates-inc
Decheng-capital
Nasdaq
Zentalis-pharmaceuticals
Eventide-asset-management
Zentalis-pharmaceuticals-company-profile
Hermes-inc

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04.06.2024 - NEW YORK & SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) - Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental .

New-york
United-states
San-diego
California
Zentalis-pharmaceuticals-inc
Zentalis-pharmaceuticals
Linkedin
Nasdaq-global-market

Insider Selling: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) CFO Sells 9,597 Shares of Stock

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $11.98, for a total transaction of $114,972.06. Following the transaction, the chief financial officer now owns 633,680 shares in the company, […]

Stifel-nicolaus
Nasdaq
Zentalis-pharmaceuticals-inc
Zentalis-pharmaceuticals-stock-performance
Vanguard-group-inc
Tower-research-capital
Sg-americas-securities
Quarter-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-company-profile
Charles-schwab-investment-management-inc
York-mellon-corp
News-ratings-for-zentalis-pharmaceuticals-daily

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) CFO Sells $114,972.06 in Stock

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $11.98, for a total value of $114,972.06. Following the sale, the chief financial officer now owns 633,680 shares in the company, […]

China
Stifel-nicolaus
Tower-research-capital
Oneascent-financial-services
Exchange-traded-concepts
Zentalis-pharmaceuticals-trading-down
Quarter-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Nasdaq
China-universal-asset-management-co
Quest-partners
News-ratings-for-zentalis-pharmaceuticals-daily

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Rating of "Moderate Buy" from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price target among […]

China
Diana-hausman
Stifel-nicolaus
Td-asset-management-inc
Zentalis-pharmaceuticals-company-profile
Analyst-recommendations-for-zentalis-pharmaceuticals
China-universal-asset-management-co
York-mellon-corp
Securities-exchange-commission
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals
Institutional-trading-of-zentalis-pharmaceuticals

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Shares Gap Up to $11.67

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Shares Gap Up to $11.67
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

China
Diana-hausman
Stifel-nicolaus
Exchange-traded-concepts
China-universal-asset-management-co
Hedge-funds-weigh-in-on-zentalis-pharmaceuticals
Nasdaq
Zentalis-pharmaceuticals-price-performance
Securities-exchange-commission
Insider-activity-at-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Oneascent-financial-services

These Are the Most Heavily Shorted Stocks Heating Up the Market

These Are the Most Heavily Shorted Stocks Heating Up the Market
247wallst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 247wallst.com Daily Mail and Mail on Sunday newspapers.

Jonathan-weiss-shutterstock
Arbor-realty-trust-inc
Holdings-inc
Carvana-co
Olema-pharmaceuticals-inc
Nine-energy-service-inc
Sunnova-energy-international-inc
Fortress-energy-inc
Editas-medicine-inc
Zentalis-pharmaceuticals-inc
Phathom-pharmaceuticals-inc
Vital-energy-inc

HC Wainwright Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $40.00

HC Wainwright Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $40.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
Stifel-nicolaus
Melissab-epperly
Diana-hausman
Zentalis-pharmaceuticals-company-profile
Eventide-asset-management
Decheng-capital
Zentalis-pharmaceuticals
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-stock-performance

vimarsana © 2020. All Rights Reserved.